Robinhood Markets, Inc.’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$194 Buy
+52
New +$255 ﹤0.01% 1021

Other funds holding RLMD

Robinhood Markets, Inc.'s RLMD Position: Q3 2026 in Review

Robinhood Markets, Inc. opened a new position in Relmada Therapeutics (RLMD) in Q3 2026: 52 shares worth $194. The stake represents ﹤0.01% of the portfolio and ranks #1021 among its holdings.

135 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.

  • Robinhood Markets, Inc. held 52 shares of Relmada Therapeutics worth $194 as of Q3 2026.
  • Relmada Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
  • Relmada Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1021 holding.
  • 135 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.

Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.